글로벌 예르시니아 진단 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 예르시니아 진단 시장

예르시니아 진단 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 CAGR로 성장하고 있으며 2028년까지 2억 9,359만 달러에 도달할 것으로 추정한다고 분석합니다. 새로운 분자 진단 도구의 채택이 증가함에 따라 예르시니아 진단 시장 성장이 확대될 것입니다.

Yersinia는 그람 양성 막대 모양의 박테리아로 Enterobacteriaceae과에 속합니다. 일반적으로 장염, 말단 회장염, 급성 설사, 장간막 림프절염, 가성 충수염 및 패혈증을 유발합니다. Yersinia의 병원성 종에는 Yersinia pestis, Yersinia enterocolitica 및 Yersinia pseudotuberculosis가 있습니다. Yersinia는 비위생적인 통조림 및 오래된 음식을 통해 인체에 유입되는 식품 매개 박테리아입니다. 돼지는 Yersinia의 주요 동물 보균원이지만 설치류, 개, 소, 토끼, 양, 고양이 및 말에서도 균주가 발견됩니다.

예측 기간 동안 예르시니아 진단 시장 성장을 촉진할 것으로 예상되는 주요 요인은 기술 개발, 사람들의 건강에 대한 의식 증가, 분자 진단 도구 수용 증가입니다. 또한 전 세계 환자 수 증가와 선진국에서 예르시니아증 유병률 증가입니다.

반면, 예르시니아 진단 제품 생산업체 간의 경쟁 심화, 의료 서비스 확대를 위한 정부 자금 지원 부족, 몇몇 단체 구매 기관의 대량 구매 등은 가까운 미래에 예르시니아 진단 제품 시장 성장을 방해할 것으로 추정되는 요인 중 일부입니다.

This yersinia diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Yersinia diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Yersinia Diagnostics Market Scope and Market Size

The yersinia diagnostics market is segmented on the basis of test type, technology and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of test type, the yersinia diagnostics market is segmented into stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy.
• On the basis of technology, the yersinia diagnostics market is segmented into DNA probes, immunoassay, monoclonal antibodies, PCR.
• On the basis of end user, the yersinia diagnostics market is segmented into hospital laboratories, public health laboratories, and commercial laboratories.

Yersinia Diagnostics Market Country Level Analysis

The yersinia diagnostics market is analysed and market size insights and trends are provided by country, test type, technology and end user as referenced above.      

The countries covered in the yersinia diagnostics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the yersinia diagnostics market due to the increase in the prevalence of the infections. Furthermore, the rise in the elderly population will further boost the growth of the yersinia diagnostics market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the yersinia diagnostics market due to the growing of the investments by government forms in order to improve the health care facilities. Moreover, the presence of unused prospects and increase in the incidences of infection is further anticipated to propel the growth of the yersinia diagnostics market in the region in the coming years.

The country section of the yersinia diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The yersinia diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yersinia diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yersinia diagnostics market. The data is available for historic period 2010-2019.

Competitive Landscape and Yersinia DiagnosticsMarket Share Analysis

The yersinia diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to yersinia diagnostics market.

yersinia 진단 시장 보고서에서 다루는 주요 기업은 Thermo Fisher Scientific, Merck KGaA, BD, bioMérieux SA, Bio-Rad Laboratories Inc., ELITechGroup Inc., GlaxoSmithKline plc., Lonza, PerkinElmer Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Siemens, SeraCare Life Sciences Inc., Abbott, Gen-probe, Hologic Inc., Danaher, Robert Bosch GmbH 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-44834